NASDAQ$ESTA
Establishment Labs Holdings Inc · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Establishment Labs reported its financial results for the fourth quarter and full year ended December 31, 2024, reaffirming its 2025 guidance.
Establishment Labs reported a fourth quarter revenue of $44.5 million, consistent with preannouncement, and a net loss from operations of $18.7 million, which was a 15% reduction compared to the prior year. The company also saw its adjusted EBITDA loss improve by 25% to $13.1 million.
- Fourth quarter revenue reached $44.5 million, aligning with earlier preannouncements.
- Motiva Implants were approved and launched in the U.S., contributing $3.3 million in U.S. revenue for the fourth quarter.
- Net loss from operations decreased by 15% to $18.7 million compared to the same period last year.
- Adjusted EBITDA loss improved by 25% to $13.1 million year-over-year.
Headline financials
Revenue & EPS history
Establishment Labs · Revenue · Quarterly
$44.5M
Forward guidance
Establishment Labs reaffirmed its 2025 revenue guidance of $205 million to $210 million, representing an increase of 23% to 26% over 2024, with U.S. revenue expected to be approximately $35 million.
Tailwinds
- Reaffirmed 2025 revenue guidance of $205 million to $210 million.
- Anticipated 23% to 26% increase in 2025 revenue over 2024.
- Expected U.S. revenue of approximately $35 million in 2025.
- First quarter 2025 U.S. revenue expected to be approximately $5.5 million.
- Targeting first positive EBITDA quarter in 2025 and positive cash flow in 2026.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
+1.5%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+2.4%
Avg return
30 days after
56%
18 / 32 earnings
Positive
+22.5%
Q3 2025
Best reaction
-26.0%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.4% | -4.3% | +2.9% | |
| Q4 2025 | -1.9% | +5.0% | -20.1% | |
| Q3 2025 | +22.5% | +37.0% | +43.2% | |
| Q1 2025 | +4.9% | +5.1% | +14.2% | |
| Q4 2024 | +17.9% | +28.1% | +12.1% | |
| Q3 2024 | -5.2% | -13.2% | -10.0% | |
| Q2 2024 | +3.4% | +20.6% | +23.5% | |
| Q1 2024 | +5.4% | +4.2% | -10.8% | |
| Q4 2023 | +15.1% | +19.6% | +28.2% | |
| Q3 2023 | -26.0% | -36.1% | -31.7% | |
| Q2 2023 | -8.4% | -12.0% | -12.2% | |
| Q1 2023 | +1.8% | -1.6% | -1.9% | |
| Q4 2022 | +7.2% | +10.3% | +0.3% | |
| Q3 2022 | -7.7% | +11.1% | +27.1% | |
| Q2 2022 | -3.0% | +1.3% | -0.4% | |
| Q1 2022 | -10.5% | -10.1% | +2.3% | |
| Q4 2021 | +3.3% | +1.6% | +11.5% | |
| Q3 2021 | -10.6% | -14.3% | -15.2% | |
| Q2 2021 | +6.0% | -3.7% | -3.1% | |
| Q1 2021 | -0.6% | -1.8% | +8.9% | |
| Q4 2020 | +0.4% | -6.8% | +9.5% | |
| Q3 2020 | +8.9% | -0.4% | +22.6% | |
| Q2 2020 | +6.2% | +7.3% | +9.3% | |
| Q1 2020 | +2.9% | +0.5% | +15.3% | |
| Q4 2019 | +4.5% | -16.4% | +0.4% | |
| Q3 2019 | -0.3% | +0.5% | +7.8% | |
| Q2 2019 | -5.2% | -10.6% | -10.2% | |
| Q1 2019 | +1.5% | -0.3% | -15.9% | |
| Q4 2018 | -1.9% | -4.9% | -15.2% | |
| Q3 2017 | +10.3% | +4.5% | -6.2% | |
| Q3 2018 | +10.3% | +4.5% | -6.2% | |
| Q2 2018 | -2.7% | -2.9% | -3.4% | |
| Q4 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro